Organization typesPublic Company

Products 21 to 30 of 122

Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: Canada + France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/11/08 14:32 (3 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Biotech components: Enzyme
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: NASEM Database
Trading symbol: MON (NYSE)
Value chain stage: Finished Product
BioIsoprene by DuPont
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Biopolymer I6001 by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/01 09:56 (3 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer I6003rp by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/01 09:56 (3 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5010 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5011 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
C3007 by Yield10 Bioscience
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Additive
Production process: Open Release
Source: Web search
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
C3010 by Yield10 Bioscience
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Additive
Production process: Open Release
Source: Web search
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Cadnano by Autodesk
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/01/30 12:03 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Design
Production process: Closed Production
Source: SynBio Database
Trading symbol: ADSK (NASDAQ)
Value chain stage: Platform